Ramiah Investment Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Ramiah Investment Group's EW Position: Q2 2026 in Review
Ramiah Investment Group reduced its Edwards Lifesciences (EW) stake by 9.3% in Q2 2026, selling an estimated $40.6K and leaving 4,709 shares worth $426K. The position accounts for 0.33% of the portfolio, ranked #49.
Ramiah Investment Group first reported a position in EW in Q2 2020 and has held it in 19 quarters since. The position peaked at $987K in Q3 2021. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Ramiah Investment Group held 4,709 shares of Edwards Lifesciences worth $426K as of Q2 2026.
- Ramiah Investment Group sold 485 Edwards Lifesciences shares in Q2 2026, an estimated $40.6K.
- Edwards Lifesciences made up 0.33% of Ramiah Investment Group's portfolio in Q2 2026, its #49 holding.
- Ramiah Investment Group first reported a position in Edwards Lifesciences in Q2 2020 and has held it in 19 quarters since.
- Ramiah Investment Group's Edwards Lifesciences position peaked at $987K in Q3 2021.
- 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Ramiah Investment Group's 13F filing for Q2 2026, filed 16 Jul 2026.